2019 and Specialty Pharmacies - Pharmacist Digest

STAT+: Sanford Health aims to shake off a run of failed deals by snapping up a $3 billion Wisconsin health system

STAT

JULY 10, 2024

Less than a year after scrapping its proposed merger with a Minnesota health system — its third failed deal since 2019 — South Dakota’s Sanford is attempting a new, multibillion-dollar mashup. Fourth time’s the charm? Sanford Health is hoping so. The systems said they plan to close the deal by the end of the year.

Specialty Pharmacies

Specialty Pharmacies Hospitals

The Top 15 Specialty Pharmacies of 2019: PBMs Stay On Top (rerun)

Drug Channels

JULY 9, 2020

In Drug Channels Institute's list of the top 15 pharmacies of 2019 , we show that many of the largest U.S. pharmacies are now central-fill mail and specialty pharmacies operated by PBMs and insurers. I see upside for specialty pharmacies in the aftermath of the pandemic.

Specialty Pharmacies

Driving Provider Value for Specialty Pharmacies

National Association of Boards of Pharmacy

NOVEMBER 6, 2024

Launched in 2019, NABP’s Specialty Pharmacy Accreditation was created to accredit pharmacies providing advanced levels of pharmacy services and disease management tools for patients taking medications that require special handling, storage, and dispensing requirements.

Specialty Pharmacies

Specialty Pharmacies Packaging Documentation

PBM-Owned Specialty Pharmacies Expand Their Role In—and Profits From—the 340B Program

Drug Channels

JULY 21, 2020

Below, we update our exclusive analysis of the biggest specialty pharmacies within 340B. The four largest specialty pharmacies are owned by CVS Health, Cigna’s Express Scripts business, UnitedHealth Group’s OptumRx business, and Walgreens Boots Alliance/Prime Therapeutics.

Specialty Pharmacies

Specialty Pharmacies Drug Pricing Documentation Hospitals

How Specialty Pharmacies Cater to the Blind and Those With Impaired Vision

NY Times

SEPTEMBER 21, 2021

The pandemic has exposed flaws in services for people who can’t easily access a drive-through window for Covid shots or testing or can’t read prescription labels.

Specialty Pharmacies

Specialty Pharmacies Labelling Packaging

The Top 15 U.S. Pharmacies of 2019: Specialty Drugs Drive the Industry’s Evolution (rerun)

Drug Channels

JULY 6, 2020

The exhibit below—one of 203 in our new report—provides a first look at the 15 largest pharmacies, ranked by total U.S. prescription dispensing revenues for calendar year 2019. As you will see, pharmacy industry prescription dispensing revenues reached a record $446 billion in 2019. d/b/a Drug Channels Institute.

Specialty Pharmacies

Specialty Pharmacies Drug Pricing

The Top 15 U.S. Pharmacies of 2019: Specialty Drugs Drive the Industry’s Evolution (rerun)

Drug Channels

JULY 6, 2020

The exhibit below—one of 203 in our new report—provides a first look at the 15 largest pharmacies, ranked by total U.S. prescription dispensing revenues for calendar year 2019. As you will see, pharmacy industry prescription dispensing revenues reached a record $446 billion in 2019. d/b/a Drug Channels Institute.

Specialty Pharmacies

Specialty Pharmacies Drug Pricing

J&J’s Own Numbers Reveal The Fallacy In Drug Manufacturers’ Objections To 340B

Proxsys Rx

OCTOBER 25, 2024

For more information on any aspect of developing & managing a successful 340B program AND/OR retail and specialty pharmacies, contact: HOWARD HALL C: 214.808.2700 | howard.hall@proxsysrx.com FULL POST According to a graphic published on its website, in 2023 Johnson & Johnson provided $42.8 CVS Specialty ( CVS Health ) — $73.3

Specialty Pharmacies

Specialty Pharmacies Hospitals Drug Pricing

Is Your 340B Vendor A Partner Or A Parasite?

Proxsys Rx

MAY 16, 2024

Here’s what that model looks like for 340B hospital clients These vendors typically charge a fee of around 10%-15% on every prescription filled in the hospital-owned pharmacy they manage. POOR on dozens, if not hundreds, of specialty pharmacy prescriptions every year. That means a 340B hospital paying a 12.5%

Specialty Pharmacies

Specialty Pharmacies Hospitals Prescription Filling

What Is Your Health System’s Potential ROI With An Optimized 340B Program?

Proxsys Rx

OCTOBER 24, 2022

We’ve published two articles on the topic — one examining the concept of program optimization itself, and the other exploring the impact contract pharmacy relationships can have on program optimization. In 2020, specialty drugs accounted for roughly half of the overall prescription drug market’s expenditures.

Specialty Pharmacies

Specialty Pharmacies Hospitals Pharmaceutical Manufacturing

Your Hospital’s 340B Contract Pharmacy Network Is Not What It Should Be.

Proxsys Rx

NOVEMBER 15, 2023

Since 2019, when ProxsysRx launched its 340B Support Services division, we’ve managed the 340B programs of 18 health systems. Negotiated pricing for specialty drugs Fees from specialty pharmacies also vary for 340B prescriptions. Most specialty pharmacies are owned and operated by PBMs. PBM relationships.

Specialty Pharmacies

Specialty Pharmacies Hospitals Independent Pharmacies

Overcome 340B ESP & Other Manufacturer Restrictions With Software And Human Insight

Proxsys Rx

AUGUST 28, 2024

PHASE THREE Building-out 340B program “infrastructure” Optimizing the number and quality of 340B eligible contract pharmacies If your health system is managing its own 340B program, there’s something you should know: Your contract pharmacy network is not what it should be. Eight tips for dealing with 340B ESP 1.

Specialty Pharmacies

Specialty Pharmacies Hospitals Communication Packaging

Your Hospital’s 340B Contract Pharmacy Network Is Not What It Should Be.

Proxsys Rx

FEBRUARY 15, 2024

Since 2019, when ProxsysRx launched its 340B Support Services division, we’ve managed the 340B programs of 18 health systems. Negotiated pricing for specialty drugs Fees from specialty pharmacies also vary for 340B prescriptions. Most specialty pharmacies are owned and operated by PBMs. PBM relationships.

Specialty Pharmacies

Specialty Pharmacies Hospitals Independent Pharmacies

340B Outlook For 2024: Change. Change. And More Change.

Proxsys Rx

APRIL 19, 2024

Between late 2019 and the end of 2023, ProxsysRx’s 340B Support program went from Zero to more than $500 million in savings generated for the hospitals and health systems we serve. Understand, and master, your 340B specialty pharmacy opportunities. The 340B revenue potential of specialty pharmacy is staggering.

Specialty Pharmacies

Specialty Pharmacies Hospitals Drug Pricing Packaging

340B Outlook For 2024: Change. Change. And More Change.

Proxsys Rx

JANUARY 12, 2024

Between late 2019 and the end of 2023, ProxsysRx’s 340B Support program went from Zero to $435 million in savings generated for the hospitals and health systems we serve. Understand, and master, your 340B specialty pharmacy opportunities. The 340B revenue potential of specialty pharmacy is staggering.

Specialty Pharmacies

Specialty Pharmacies Hospitals Drug Pricing Packaging

NHC Comments on Request for Information: Medicare Transaction Facilitator (MTF) for the Medicare Drug Price Negotiation Program

Putting Patients First Blog

NOVEMBER 14, 2023

Pharmacy benefit managers: transparency, accountability, and impact on patient care. Journal of Managed Care & Specialty Pharmacy, 27(7), 903-907. Drug Distribution Data 2019. Drug Distribution Data 2019. Update: independently owned pharmacy closures in rural America, 2003-2018. Blendon, R., Casalino, L.,

Drug Pricing

Drug Pricing Specialty Pharmacies HIPAA Payment Processing

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

JULY 2, 2024

Pharmacy benefit managers: transparency, accountability, and impact on patient care. Journal of Managed Care & Specialty Pharmacy, 27(7), 903-907. Retrieved from [link] content/uploads/2022/05/NHC-FTC-PBM-Comments-Final-Plain-Letterhead.pdf iv Kyle, M., Blendon, R., and Schnieder, E. Casalino, L., and Richman, B. Hochberg M.,

Drug Pricing

Drug Pricing Insurance Coverage and Processing Labelling HIPAA

2275 pharmacies have closed so far in 2024

Ramblings of a pharmacist

SEPTEMBER 16, 2024

drop in number of pharmacy locations nationwide. in JAMA in 2019 , for example, shows that an average of 1631 pharmacies closed each year as reported in NCPDP from 2010 to 2015, with and average of 2435 pharmacies opening each year for a net average figure of 804 openings every year in that period. .”

Health and Personal Care Stores

Health and Personal Care Stores Independent Pharmacies Pharmacy Technician Specialty Pharmacies

Ep. 003 – Ritesh Patel Podcast Transcript

Pharma Marketing Network

JUNE 10, 2020

And also, the amount of money that’s being poured into this and with north of $9 billion in 2019. I think that 2018, 2019 I will tell you, I think I’m looking at already 12 to 14 billion is my prediction for the end of 2019 would north of probably 1000 deals going through with a couple of exits as well.

Hospitals

Hospitals Specialty Pharmacies Medical Records Packaging

Ep. 003 – Ritesh Patel Podcast Transcript

Pharma Marketing Network

JUNE 10, 2020

And also, the amount of money that’s being poured into this and with north of $9 billion in 2019. I think that 2018, 2019 I will tell you, I think I’m looking at already 12 to 14 billion is my prediction for the end of 2019 would north of probably 1000 deals going through with a couple of exits as well.

Hospitals

Hospitals Specialty Pharmacies Medical Records Packaging

Assessing physician practices and expectations in the post-COVID era

pharmaphorum

JANUARY 22, 2021

More than 100,000 MS patients were included in the data set, defined as patients with two or more MS-related medical claims or one or more MS-related medical claims plus a related pharmacy claim identified between January 2019 and June 2020. Impact on patients.

Specialty Pharmacies

Specialty Pharmacies Pharmaceutical Companies Pharmaceutical Companies Vaccines

NHC Comments on Notice of Proposed Rulemaking on Discrimination on the Basis of Disability in Health and Human Service Programs or Activities

Putting Patients First Blog

NOVEMBER 14, 2023

A 2019 study highlighted that physicians’ biases could influence their clinical decision-making, which underscores the importance of awareness and training to mitigate such biases.15 Chronic pain among adults – United States, 2019-2021. Journal of Managed Care and Specialty Pharmacy, 27(9-a Suppl), doi: 10.18553/jmcp.2021.27.9-a.s17

Communication

Communication Hospitals Bioethics Documentation

Pharmacist Digest

STAT+: Sanford Health aims to shake off a run of failed deals by snapping up a $3 billion Wisconsin health system

The Top 15 Specialty Pharmacies of 2019: PBMs Stay On Top (rerun)

Trending Sources

Driving Provider Value for Specialty Pharmacies

PBM-Owned Specialty Pharmacies Expand Their Role In—and Profits From—the 340B Program

How Specialty Pharmacies Cater to the Blind and Those With Impaired Vision

The Top 15 U.S. Pharmacies of 2019: Specialty Drugs Drive the Industry’s Evolution (rerun)

The Top 15 U.S. Pharmacies of 2019: Specialty Drugs Drive the Industry’s Evolution (rerun)

J&J’s Own Numbers Reveal The Fallacy In Drug Manufacturers’ Objections To 340B

Is Your 340B Vendor A Partner Or A Parasite?

What Is Your Health System’s Potential ROI With An Optimized 340B Program?

Your Hospital’s 340B Contract Pharmacy Network Is Not What It Should Be.

Overcome 340B ESP & Other Manufacturer Restrictions With Software And Human Insight

Your Hospital’s 340B Contract Pharmacy Network Is Not What It Should Be.

340B Outlook For 2024: Change. Change. And More Change.

340B Outlook For 2024: Change. Change. And More Change.

NHC Comments on Request for Information: Medicare Transaction Facilitator (MTF) for the Medicare Drug Price Negotiation Program

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

2275 pharmacies have closed so far in 2024

Ep. 003 – Ritesh Patel Podcast Transcript

Ep. 003 – Ritesh Patel Podcast Transcript

Assessing physician practices and expectations in the post-COVID era

NHC Comments on Notice of Proposed Rulemaking on Discrimination on the Basis of Disability in Health and Human Service Programs or Activities

Stay Connected